Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients
- 26 January 2015
- journal article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 21 (6), 675-676
- https://doi.org/10.1177/1352458514564494
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical Relevance of Brain Volume Measures in Multiple SclerosisCNS Drugs, 2014
- Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studiesNeuroImage: Clinical, 2014
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosisAnnals of Neurology, 2013
- Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesMultiple Sclerosis Journal, 2013
- Association between pathological and MRI findings in multiple sclerosisThe Lancet Neurology, 2012
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisNeurology, 2008
- Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosisNeurology, 2006
- The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosisZeitschrift für Neurologie, 2004
- Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis: A Comparative Quantitative Study of Axonal Injury in Active, Inactive, and Remyelinated LesionsThe American Journal of Pathology, 2000